JLE

Epileptic Disorders

MENU

Prognostic factors of status epilepticus in adults Volume 18, numéro 3, September 2016

  • [Alvarez et al., 2011] Alvarez V., Januel J.M., Burnand B., Rossetti A.O. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52:1292-1296. 7
  • [Aranda et al., 2010] Aranda A., Foucart G., Ducasse J.L. Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice. Epilepsia. 2010;51:2159-2167. 10
  • [Brigo et al., 2015] Brigo F., Nardone R., Tezzon, Trinka E. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: a systematic review with meta-analysis. Epilepsy Behav. 2015;49:325-336.
  • [Brophy et al., 2012] Brophy G.M., Bell R., Claassen J. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3-23. 1
  • [Canoui-Poitrine et al., 2011] Canoui-Poitrine F., Bastuji-Garin S., Alonso E. Risk and prognostic factors of status epilepticus in the elderly: a case-control study. Epilepsia. 2011;52:1849-1856. 10
  • [Claassen et al., 2002a] Claassen J., Hirsch L.J., Emerson R.G., Mayer S.A. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146-153. 2
  • [Claassen et al., 2002b] Claassen J., Lokin J.K., Fitzsimmons B.F., Mendelsohn F.A., Mayer S.A. Predictors of functional disability and mortality after status epilepticus. Neurology. 2002;58:139-142. 1
  • [Coeytaux et al., 2000] Coeytaux A., Jallon P., Galobardes B., Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology. 2000;55:693-697. 5
  • [DeLorenzo et al., 1996] DeLorenzo R.J., Hauser W.A., Towne A. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029-1035. 4
  • [DeLorenzo et al., 1999] DeLorenzo R.J., Garnett L.K., Towne A.R. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia. 1999;40:164-169. 2
  • [Dham et al., 2014] Dham B.S., Hunter K., Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20:476-483. 3
  • [Drislane et al., 2009] Drislane F.W., Blum A.S., Lopez M.R., Gautam S., Schomer D.L. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia. 2009;50:1566-1571. 6
  • [Hocker et al., 2013] Hocker S.E., Britton J.W., Mandrekar J.N., Wijdicks E., Rabinstein A.A. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70:72-77. 1
  • [Hocker et al., 2014] Hocker S., Tatum W.O., LaRoche S., Freeman W.D. Refractory and super-refractory status epilepticus-an update. Curr Neurol Neurosci Rep. 2014;14:452. 6
  • [Kapur and Macdonald, 1997] Kapur J., Macdonald R.L. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci. 1997;17:7532-7540. 19
  • [Knake et al., 2001] Knake S., Rosenow F., Vescovi M. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia. 2001;42:714-718. 6
  • [Lai et al., 2015] Lai A., Outin H.D., Jabot J. Functional outcome of prolonged refractory status epilepticus. Crit Care. 2015;19:199. 1
  • [Lowenstein and Alldredge, 1993] Lowenstein D.H., Alldredge B.K. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43:483-488. 3
  • [Marchi et al., 2015] Marchi N.A., Novy J., Faouzi M. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43:1003-1009. 5
  • [Meierkord et al., 2010] Meierkord H., Boon P., Engelsen B. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17:348-355. 3
  • [Meldrum and Horton, 1973] Meldrum B.S., Horton R.W. Physiology of status epilepticus in primates. Arch Neurol. 1973;28:1-9. 1
  • [Neligan and Shorvon, 2010] Neligan A., Shorvon S.D. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol. 2010;67:931-940. 8
  • [Novy et al., 2010] Novy J., Logroscino G., Rossetti A.O. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51:251-256. 2
  • [Power et al., 2011] Power K.N., Flaatten H., Gilhus N.E., Engelsen B.A. Propofol treatment in adult refractory status epilepticus. Mortality risk and outcome. Epilepsy Res. 2011;94:53-60. 1-2
  • [Power et al., 2015] Power K.N., Gramstad A., Gilhus N.E., Engelsen B.A. Adult nonconvulsive status epilepticus in a clinical setting: semiology, aetiology, treatment and outcome. Seizure. 2015;24:102-106.
  • [Rossetti et al., 2006] Rossetti A.O., Hurwitz S., Logroscino G., Bromfield E.B. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006;77:611-615. 5
  • [Rossetti et al., 2008] Rossetti A.O., Logroscino G., Milligan T.A. Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255:1561-1566. 10
  • [Rossetti et al., 2013] Rossetti A.O., Alvarez V., Januel J.M., Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol. 2013;260:421-428. 2
  • [Sagduyu et al., 1998] Sagduyu A., Tarlaci S., Sirin H. Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality. J Neurol. 1998;245:640-646. 10
  • [Shah et al., 2009] Shah A.M., Vashi A., Jagoda A. Review article: convulsive and non-convulsive status epilepticus: an emergency medicine perspective. Emerg Med Australas. 2009;21:352-366. 5
  • [Shorvon and Ferlisi, 2011] Shorvon S., Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802-2818. 10
  • [Shorvon et al., 2008] Shorvon S., Baulac M., Cross H., Trinka E., Walker M. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia. 2008;49:1277-1285. 7
  • [Towne et al., 1994] Towne A.R., Pellock J.M., Ko D., DeLorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27-34. 1
  • [Trinka et al., 2015] Trinka E., Cock H., Hesdorffer D. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56:1515-1523. 10
  • [Tsetsou et al., 2015] Tsetsou S., Novy J., Rossetti A.O. Recurrence of status epilepticus: prognostic role and outcome predictors. Epilepsia. 2015;56:473-478. 3
  • [Vignatelli et al., 2003] Vignatelli L., Tonon C., D’Alessandro R. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia. 2003;44:964-968. 7
  • [Walker et al., 2005] Walker M., Cross H., Smith S. Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord. 2005;7:253-296. 3
  • [Yasiry and Shorvon, 2014] Yasiry Z., Shorvon S.D. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: a meta-analysis of published studies. Seizure. 2014;23:167-174. 3